期刊文献+

中国18~59岁人群乙型病毒性肝炎流行病学特征分析及乙型肝炎疫苗免疫策略探讨 被引量:116

Analysis of Epidemiological Characteristics of Hepatitis B among the Population of 18-59 Yearold and HepB Immunization Strategies
原文传递
导出
摘要 目的分析中国(未包括香港、澳门特别行政区和台湾地区,下同)18~59岁人群乙型病毒性肝炎(乙肝)的流行病学特征和接种乙肝疫苗(Hepatitis B Vaccine,HepB)的现状,以及感染乙肝病毒(Hepatitis B Virus,HBV)的风险,探讨HepB的免疫策略。方法采用描述流行病学方法,分析2007~2012年中国疾病监测信息管理系统报告的乙肝病例的年龄别发病情况,以及1979年、1992年和2006年全国乙肝血清流行病学调查数据库。结果中国18~59岁人群急性乙肝报告发病率居高不下,易感人群的HepB接种率较低,感染风险较高。结论中国在成功实施新生儿HepB接种和儿童HepB查漏补种后,应适时开展18~59岁重点人群的HepB接种,进一步降低HBV感染率。 Objective To analyze the hepatitis B epidemiological characteristics and hepatitis B vaccine ( HepB ) vaccination status among the population aged 18-59 years in China ( excluding Hongkong Special Administrative Regions,Macao Special Administrative Regions and Taiwan Sheng ) and to suggest the hepatitis B vaccine immunization strategy for this group population.Method Descriptive epidemiological study was used by analyzing the age-specific incidence of acute hepatitis B reported by Chinese national disease surveillance reporting system,in addition to analyzing the results of three seroepidemiological survey of hepatitis B conducted nationwide in 1979,1992 and in 2006.Results The incidence of acute hepatitis B among people aged 18-59 years remains high while the HepB vaccination rate is quite low among people susceptible to hepatitis B virus ( HBV ),which reveals the high risk of being infected with HBV.Conclusion After successfully integrated HepB into infants and to conduct the catch up vaccination in the children,China should gradually conduct HepB vaccination among people aged from eighteen to fifty-nine years,so as to decrease the prevalence of HBV.
出处 《中国疫苗和免疫》 CAS 2013年第3期266-270,共5页 Chinese Journal of Vaccines and Immunization
基金 国家科学技术"艾滋病和病毒性肝炎等重大传染病防治"重大专项"乙型肝炎病毒免疫预防新策略的研究"课题(编号2012ZX10002001)
关键词 18~59岁人群 乙型病毒性肝炎 流行病学特征 乙型肝炎疫苗 免疫策略 Population aged 18-59 years Hepatitis B Epidemiological characteristics Hepatitis B vaccine Immunization strategy
  • 相关文献

参考文献7

二级参考文献19

  • 1徐丽,邵祝军,李马超,任红宇,梁晓峰,杨俊峰,李军红,高源.脑膜炎奈瑟菌对12种抗菌药物体外敏感性检测[J].中国计划免疫,2006,12(1):53-55. 被引量:34
  • 2王玲芬,赵素莲,梁京辉.全国2000~2005年重大食物中毒情况分析[J].中国卫生监督杂志,2006,13(4):280-281. 被引量:23
  • 3国务院.突发公共卫生事件应急条例[Z].,2003.5.
  • 4卫生部.国家突发公共卫生事件相关信息报告管理工作规范(试行).2006.
  • 5Koplan J. CDC' s strategic plan for bioterrorism preparedness and response. Public Health Rep, 2001,116 Suppl 2 : S9-16.
  • 6Ashford DA, Kaiser RM, Bales ME, et al. Planning against biological terrorism: lessons from outbreak investigations. Emerg Infect Dis, 2003,9(5) :515-519.
  • 7Murray PR, Baron EJ, Jorgensen JH, et al. Neisseria and Moraxella catarrhalis, Manual of clinical microbiology [M]. 8th Edition ,ASM , Washington DC,2003 : 585 - 608.
  • 8Quagliarello VJ, Scheld WM. Treatment of bacterial meningtitis [J]. N EngJ Med, 1997,336:708 - 716.
  • 9Sutcliffe EM, Jone DM. Penicillin-insensitive mening ococci in the UK[J]. Lmcet ,1998 :657 -658.
  • 10Hansman D, Waft S, Lawrence A, et al. Have South Australia isolates of Neisseria meningitides become less susceptible to penicillin, rifampicin and other drugs A study of strains isolated over three decades,1971 - 1999[J]. Pathology ,2004 ,36 :160 - 165.

共引文献58

同被引文献962

引证文献116

二级引证文献662

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部